1 Market Overview
1.1 Oncology Injection Drug Introduction
1.2 Market Analysis by Type
1.2.1 Organs
1.2.2 Central Nervous System
1.2.3 Circulatory/Musculoskeletal System
1.3 Market Analysis by Applications
1.3.1 Lymphoma
1.3.2 Myeloma
1.3.3 Prostate Cancer
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Taj Oncology
2.1.1 Business Overview
2.1.2 Oncology Injection Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Taj Oncology Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.2 S.G. Biopharm
2.2.1 Business Overview
2.2.2 Oncology Injection Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 S.G. Biopharm Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.3 AdvaCare
2.3.1 Business Overview
2.3.2 Oncology Injection Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AdvaCare Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.4 Merrimack
2.4.1 Business Overview
2.4.2 Oncology Injection Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merrimack Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.5 Celgene
2.5.1 Business Overview
2.5.2 Oncology Injection Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Celgene Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.6 Allos Therapeutics
2.6.1 Business Overview
2.6.2 Oncology Injection Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Allos Therapeutics Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.7 Ferring Pharmaceuticals
2.7.1 Business Overview
2.7.2 Oncology Injection Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.8 Genzyme
2.8.1 Business Overview
2.8.2 Oncology Injection Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Genzyme Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.9 Eli Lilly
2.9.1 Business Overview
2.9.2 Oncology Injection Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eli Lilly Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.10 Praecis Pharmaceuticals
2.10.1 Business Overview
2.10.2 Oncology Injection Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.11 Millennium Pharmaceuticals
2.11.1 Business Overview
2.11.2 Oncology Injection Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.12 Debiopharm
2.12.1 Business Overview
2.12.2 Oncology Injection Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Debiopharm Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.13 Alza
2.13.1 Business Overview
2.13.2 Oncology Injection Drug Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Alza Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.14 CordenPharma
2.14.1 Business Overview
2.14.2 Oncology Injection Drug Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 CordenPharma Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.15 Pharmascience
2.15.1 Business Overview
2.15.2 Oncology Injection Drug Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Pharmascience Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Oncology Injection Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Oncology Injection Drug Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Oncology Injection Drug Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Oncology Injection Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Oncology Injection Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Oncology Injection Drug Market Analysis by Regions
4.1 Global Oncology Injection Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Oncology Injection Drug Sales and Market Share by Regions (2015-2019)
4.1.2 Global Oncology Injection Drug Revenue and Market Share by Regions (2015-2019)
4.2 North America Oncology Injection Drug Sales and Growth Rate (2015-2019)
4.3 Europe Oncology Injection Drug Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Oncology Injection Drug Sales and Growth Rate (2015-2019)
4.5 South America Oncology Injection Drug Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Oncology Injection Drug Sales and Growth Rate (2015-2019)
5 North America Oncology Injection Drug by Country
5.1 North America Oncology Injection Drug Sales, Revenue and Market Share by Country
5.1.1 North America Oncology Injection Drug Sales and Market Share by Country (2015-2019)
5.1.2 North America Oncology Injection Drug Revenue and Market Share by Country (2015-2019)
5.2 United States Oncology Injection Drug Sales and Growth Rate (2015-2019)
5.3 Canada Oncology Injection Drug Sales and Growth Rate (2015-2019)
5.4 Mexico Oncology Injection Drug Sales and Growth Rate (2015-2019)
6 Europe Oncology Injection Drug by Country
6.1 Europe Oncology Injection Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Oncology Injection Drug Sales and Market Share by Country (2015-2019)
6.1.2 Europe Oncology Injection Drug Revenue and Market Share by Country (2015-2019)
6.2 Germany Oncology Injection Drug Sales and Growth Rate (2015-2019)
6.3 UK Oncology Injection Drug Sales and Growth Rate (2015-2019)
6.4 France Oncology Injection Drug Sales and Growth Rate (2015-2019)
6.5 Russia Oncology Injection Drug Sales and Growth Rate (2015-2019)
6.6 Italy Oncology Injection Drug Sales and Growth Rate (2015-2019)
7 Asia-Pacific Oncology Injection Drug by Country
7.1 Asia-Pacific Oncology Injection Drug Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Oncology Injection Drug Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Oncology Injection Drug Revenue and Market Share by Country (2015-2019)
7.2 China Oncology Injection Drug Sales and Growth Rate (2015-2019)
7.3 Japan Oncology Injection Drug Sales and Growth Rate (2015-2019)
7.4 Korea Oncology Injection Drug Sales and Growth Rate (2015-2019)
7.5 India Oncology Injection Drug Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Oncology Injection Drug Sales and Growth Rate (2015-2019)
8 South America Oncology Injection Drug by Country
8.1 South America Oncology Injection Drug Sales, Revenue and Market Share by Country
8.1.1 South America Oncology Injection Drug Sales and Market Share by Country (2015-2019)
8.1.2 South America Oncology Injection Drug Revenue and Market Share by Country (2015-2019)
8.2 Brazil Oncology Injection Drug Sales and Growth Rate (2015-2019)
8.3 Argentina Oncology Injection Drug Sales and Growth Rate (2015-2019)
8.4 Colombia Oncology Injection Drug Sales and Growth Rate (2015-2019)
9 Middle East and Africa Oncology Injection Drug by Countries
9.1 Middle East and Africa Oncology Injection Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Oncology Injection Drug Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Oncology Injection Drug Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Oncology Injection Drug Sales and Growth Rate (2015-2019)
9.3 Turkey Oncology Injection Drug Sales and Growth Rate (2015-2019)
9.4 Egypt Oncology Injection Drug Sales and Growth Rate (2015-2019)
9.5 Nigeria Oncology Injection Drug Sales and Growth Rate (2015-2019)
9.6 South Africa Oncology Injection Drug Sales and Growth Rate (2015-2019)
10 Global Oncology Injection Drug Market Segment by Type
10.1 Global Oncology Injection Drug Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Oncology Injection Drug Sales and Market Share by Type (2015-2019)
10.1.2 Global Oncology Injection Drug Revenue and Market Share by Type (2015-2019)
10.2 Organs Sales Growth and Price
10.2.1 Global Organs Sales Growth (2015-2019)
10.2.2 Global Organs Price (2015-2019)
10.3 Central Nervous System Sales Growth and Price
10.3.1 Global Central Nervous System Sales Growth (2015-2019)
10.3.2 Global Central Nervous System Price (2015-2019)
10.4 Circulatory/Musculoskeletal System Sales Growth and Price
10.4.1 Global Circulatory/Musculoskeletal System Sales Growth (2015-2019)
10.4.2 Global Circulatory/Musculoskeletal System Price (2015-2019)
11 Global Oncology Injection Drug Market Segment by Application
11.1 Global Oncology Injection Drug Sales Market Share by Application (2015-2019)
11.2 Lymphoma Sales Growth (2015-2019)
11.3 Myeloma Sales Growth (2015-2019)
11.4 Prostate Cancer Sales Growth (2015-2019)
12 Oncology Injection Drug Market Forecast (2020-2025)
12.1 Global Oncology Injection Drug Sales, Revenue and Growth Rate (2020-2025)
12.2 Oncology Injection Drug Market Forecast by Regions (2020-2025)
12.2.1 North America Oncology Injection Drug Market Forecast (2020-2025)
12.2.2 Europe Oncology Injection Drug Market Forecast (2020-2025)
12.2.3 Asia-Pacific Oncology Injection Drug Market Forecast (2020-2025)
12.2.4 South America Oncology Injection Drug Market Forecast (2020-2025)
12.2.5 Middle East and Africa Oncology Injection Drug Market Forecast (2020-2025)
12.3 Oncology Injection Drug Market Forecast by Type (2020-2025)
12.3.1 Global Oncology Injection Drug Sales Forecast by Type (2020-2025)
12.3.2 Global Oncology Injection Drug Market Share Forecast by Type (2020-2025)
12.4 Oncology Injection Drug Market Forecast by Application (2020-2025)
12.4.1 Global Oncology Injection Drug Sales Forecast by Application (2020-2025)
12.4.2 Global Oncology Injection Drug Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source